360° Coverage : Paid Constipation Clinical Trial Now Enrolling at Achieve...

2 Updates

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or...

Filed under: news

YouTube Videos Tweets

 
 
 

50 weeks ago

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This is a multicenter, double-blind, placebo-controlled, parallel-group study in participants with opioid-induced constipation who are taking opioid therapy for chronic non-cancer pain. Participants will be randomized in a 1:1 ratio to receive the new constipation drug or matching placebo. The study will consist of 3 periods: a screening period of up to 21 days, a 52-week double-blind treatment period, and a 4-week follow-up period.

Background & Rational
Patients who take opioids often suffer from constipation and associated gastrointestinal side effects (e.g., abdominal cramping, abdominal bloating, excess gas) for as long as they remain on opioid therapy. Based on the reported literature and previous clinical trials, these patients often suffer from constipation for many years thus requiring long-term management for this condition.

Opioid-induced constipation has a negative impact on a patient’s quality of life and, if not treated effectively, can lead to serious complications including obstipation and bowel perforation. Moreover, patients may discontinue opioids because of the associated constipation, thereby compromising their pain management and increasing the risk of systemic opioid withdrawal.

No drug has been approved as monotherapy for the treatment of constipation in patients taking opioid therapy for chronic non-cancer pain. Current treatment options are limited: they include stool softeners and laxatives; diet and exercise; and opioid dose-reduction, switching, or discontinuation. However, these treatments are often ineffective, associated with significant GI side effects, and burdensome to patients.

Primary Objective
Evaluate the safety and tolerability of this experimental constipation drug in human participants over 12 months, relative to a placebo.

Inclusion Criteria
To be eligible for enrollment, a subject must meet all of the following criteria before any study-related procedures are conducted:

Is able to understand and comply with the study procedures and voluntarily provide written informed consent
Is a man or woman aged 18 to 80 years, inclusive, at the time of Screening
Has a body weight of ≥ 45 kg and a body mass index (BMI) ≤ 45 kg/m
Has not achieved adequate relief with other treatments for constipation (e.g., laxatives)
Is taking a stable daily dose of opioids of ≥ 30-mg morphine-equivalent total daily dose (METDD) for chronic non-cancer pain for ≥ 30 days before Screening and expected to continue on a dose of ≥ 30-mg METDD for the duration of the study
Is taking opioids via oral, transmucosal, sublingual, or transdermal routes of administration (intrathecal opioids via pump are permitted provided they are taken in addition to a full opioid agonist meeting the METDD requirement)
Has constipation that is caused by the chronic use of opioids and has the following self-reported symptoms of constipation that a) have occurred in temporal association with and directly related to starting opioid therapy, b) have persisted since starting opioid therapy, and c) have been present for ≥ 2 months:

-- Decreased BM frequency and
≥ 1 other BM symptom (i.e., straining to pass a stool, lumpy hard stools or small pellets, or sense of incomplete evacuation after passing a stool)

If female, subjects must not be pregnant (confirmed via pregnancy test at Screening and Day 1), and must meet either Criterion (a) or Criterion (b) below:

Is not of childbearing potential: defined as postmenopausal (i.e., having no menses for ≥ 1 year without an alternative medical cause) or surgically sterile because of bilateral tubal ligation, bilateral oophorectomy, or hysterectomy
Is of childbearing potential, meets 1 of the following 4 criteria:
Is abstaining from sexual intercourse
Is using an insertable, injectable, transdermal, or combination oral contraceptive for ≥ 1 cycle before randomization through 30 days after the subject’s last dose of study medication
Is practicing a double-barrier method of birth control (if composed of a spermicide with either a condom or diaphragm)
Has a vasectomized partner (and is using a spermicide, condom, or diaphragm)

*Achieve Clinical Research conducts Phase II-IV Clinical Trials in Alabama. For more information about participating in a Constipation Clinical Study, please visit our website or contact us directly at (205) 380-6434.

Contact Information:
Achieve Clinical Research
Lashondra Cade
(205) 380-6434 320
Contact via Email
www.achieveclinical.com

Read the full story here: http://www.pr.com/press-release/513110

Press Release Distributed by PR.com

Source: PR.com

 
Update
2

Tweets

 
 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Want chairs made of cocoa?
London, Aug 21 (IANS) Want to buy an eco-friendly chair, a synthetic rug or a plastic bag that is made out of cocoa, rice and vegetable waste? These will soon be in a store near you.
 
 
Ebola toll rises to 1,350: WHO
Geneva, Aug 21 (IANS/EFE) The death toll due to the Ebola virus continues to rise in West Africa and currently stands at 1,350, the World Health Organisation (WHO) said.
 
 
India charges Nepal lowest interest rate
Kathmandu, Aug 21 (IANS) Compared to other South Asian countries, India charges Nepal the lowest interest rate for the lines of credit (LOCs) it offers, a diplomat here said.
 
 
An abusive boss can make entire team hostile
New York, Aug 21 (IANS) Is your boss abusive and does not pay much heed to even positive suggestions made by the team? Such superiors can actually throw the entire work team into conflict, hurting productivity, reveals a study.
 
 
 

Latest from the Network

Aaron Paul to host Breaking Bad hunt
Aaron Paul is hosting a 'Breaking Bad' scavenger hunt next week. The 34-year-old actor has thanked fans for their support throughout all five seasons of the show - in which he played meth manufacturer Jesse Pinkman -...
Read more on Celebrity Balla
 
Want chairs made of cocoa?
London, Aug 21 (IANS) Want to buy an eco-friendly chair, a synthetic rug or a plastic bag that is made out of cocoa, rice and vegetable waste? These will soon be in a store near you. The Italian scientists have found...
Read more on Apple Balla
 
Real Madrid aim for big-six season
Madrid, Aug 21 (IANS) If pre-season results were anything to look on then Real Madrid coach Carlo Ancelotti would be feeling hot under the collar and looking anxiously over his shoulder following four defeats, one win...
Read more on Sport Balla
 
Israel killed three senior commanders: Hamas military wing
Gaza, Aug 21 (IANS) The al-Qassam Brigades, the military wing of the Islamist Hamas movement, Thursday said that Israel has killed three of its senior commanders in the Gaza Strip. It said the three commanders were...
Read more on Politics Balla
 
Ebola toll rises to 1,350: WHO
Geneva, Aug 21 (IANS/EFE) The death toll due to the Ebola virus continues to rise in West Africa and currently stands at 1,350, the World Health Organisation (WHO) said. Of that number, 576 have died in Liberia where...
Read more on Business Balla
 
India charges Nepal lowest interest rate
Kathmandu, Aug 21 (IANS) Compared to other South Asian countries, India charges Nepal the lowest interest rate for the lines of credit (LOCs) it offers, a diplomat here said. "This shows India's close affinity to...
Read more on Politics Balla
 
An abusive boss can make entire team hostile
New York, Aug 21 (IANS) Is your boss abusive and does not pay much heed to even positive suggestions made by the team? Such superiors can actually throw the entire work team into conflict, hurting productivity, reveals...
Read more on Apple Balla
 
Paltrow okay with Martin's relationship with Lawrence
Los Angeles, Aug 21 (IANS) Actress Gwyneth Paltrow reportedly approves of estranged husband Chris Martin's romance with Jennifer Lawrence. The "Iron Man 3" star, who recently started dating "Glee" co-creator Brad...
Read more on Celebrity Balla
 
Bradley Cooper reveals his love of Oasis
Hollywood superstar Bradley Cooper is a big fan of Oasis. Bradley, 39, has revealed his love of the group - who officially split in 2009 after a string of high-profile disagreements between Noel and Liam Gallagher - was...
Read more on Movie Balla
 
Dan Stevens gets in shape for The Guest
Dan Stevens has got himself in shape to play a former American soldier in 'The Guest'. The 31-year-old actor is almost physically unrecognisable from the character of Matthew Crawley, who he played in the popular...
Read more on Movie Balla